Live Breaking News & Updates on Lucile Dzen

Stay updated with breaking news from Lucile dzen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023

The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker.Two additional scientific abstracts from the NATIVE Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH have been selected for presentation. The two abstracts show: the correlation between the increase of adiponectin under lanifibranor and the improvement of histological and serum markers of NASH severity both in terms of activity and ....

Israel General , United States , New York , Martine Baudin , Louis Griffel , Jean Louis Junien , Romina Lomonaco , Sven Francque , Srilaxmi Kalavalapalli , Manalf Abdelmalek , Philippe Huot Marchand , Eddison Godinez Leiva , Pierre Broqua , Aude Lepreux , Lucile Dzen , Michaelp Cooreman , Pascaline Clerc , Andrea Ortiz Rocha , Brunswick Group , University Of Florida , Patricial Bank , Corporate Affairs , Kenneth Cusi , Long Island City , Euronext Paris , Liver Meeting ,